Product
CSB-001
Aliases
CSB-001 Ophthalmic Solution 0.1%
3 clinical trials
3 indications
Indication
Neurotrophic KeratopathyIndication
Corneal ScarIndication
Limbal Stem Cell DeficiencyClinical trial
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis SubjectsStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
A Single-Arm Open-Label Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal ScarsStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Single-Arm Open-Label Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell DeficiencyStatus: Recruiting, Estimated PCD: 2025-08-01